Windlas Biotech Ltd. (WINDLAS): Windlas Biotech Share Price hits fresh 52-week high at Rs 1,080
- September 2, 2026
- Posted by: Harsh Piplani
- Category: News
Windlas Biotech Share Price moved to Rs 1,080 on 02 September 2026 at 9:51 AM IST, up 7.19% from the previous close of Rs 1,007.6. The stock touched a fresh 52-week high of Rs 1,093.05 during the session, while its market capitalisation stood at Rs 2,050.73 crore. Windlas Biotech Share Price Today is therefore drawing attention as a verified price event rather than a story built on speculation.
The day’s move started from an open of Rs 1,022.9, with the stock trading between Rs 1,017.25 and Rs 1,093.05. Turnover stood at Rs 1.56 crore. The data confirms that Windlas Biotech Share Price News is centered on a yearly high event, but it does not establish a company-specific catalyst. Univest is tracking the move as part of its fresh 52-week high coverage, where factual price action and valuation context matter more than assumptions.
For readers following Windlas Biotech Share Price Live, the combination of a new yearly high, a Rs 2,050.73 crore market cap, and sector benchmark comparison makes the stock relevant in today’s Indian stock market discussion. The next sections explain what happened, how the valuation compares within Pharmaceuticals & Drugs, and what investors should monitor next using only verified data.
Windlas Biotech Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,080 |
| Previous Close | Rs 1,007.6 |
| Today's Move | +Rs 72.4 (+7.19%) |
| Open | Rs 1,022.9 |
| High | Rs 1,093.05 |
| Low | Rs 1,017.25 |
| Turnover | Rs 1.56 crore |
| Market Capitalisation | Rs 2,050.73 crore |
Windlas Biotech Ltd. (WINDLAS) traded at Rs 1,080 versus the previous close of Rs 1,007.6, a rise of 7.19%. The stock opened at Rs 1,022.9, reached a high of Rs 1,093.05 and touched a low of Rs 1,017.25.
Windlas Biotech Share Price Today shows a clean session move from Rs 1,007.6 to Rs 1,080, with a gain of Rs 72.4. The stock’s day high and 52-week high were both Rs 1,093.05, which means the yearly high was set in the same session. Day low was Rs 1,017.25 and the opening price was Rs 1,022.9. Turnover was Rs 1.56 crore, giving a factual picture of the trading day without reading motives into it.
In practical terms, Windlas Biotech Share Price News is notable because the stock moved above its previous 52-week high of Rs 1,093.05 only momentarily before settling at Rs 1,080. The market update shows a strong day in absolute terms, but the verified data should be read as a price event, not as proof of any fresh company development. For searchers looking for Windlas Biotech Share Price Update, the key facts are the close, the intraday high and the turnover.
Windlas Biotech Share Price also compares favorably with its recent session range, and the move places the stock in the day’s 52 Week High Stocks conversation. That said, the article remains grounded in observed data: a higher close than the prior day, a new yearly high, and a turnover figure that confirms trading activity in value terms. The broader interpretation belongs to the company’s fundamentals and sector context.
Windlas Biotech Ltd. (WINDLAS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,050.73 crore |
| P/E Ratio | 31.29x |
| P/B Ratio | 4.04x |
| ROE | 12.52% |
| ROCE | 16.06% |
| EPS | Rs 32.2 |
| Book Value Per Share | Rs 249.16 |
| Dividend Yield | 0.63% |
Windlas Biotech Ltd. (WINDLAS) fundamental metrics show P/E 31.29x, P/B 4.04x, ROE 12.52%, ROCE 16.06%. These figures provide context only and are not a buy or sell signal.
Windlas Biotech Ltd. has a market capitalisation of Rs 2050.73 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.29x, P/B at 4.04x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.52% and ROCE of 16.06%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 32.2, book value per share of Rs 249.16, dividend yield of 0.63%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.16x, median ROE of 11.78%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.29x |
| Benchmark Median P/E | 31.16x |
| Benchmark Average P/E | 48.22x |
| Benchmark P/E Range | 3.68x to 653.31x |
| Company P/B Ratio | 4.04x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 12.52% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 16.06% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 2,050.73 crore |
| Benchmark Median Market Cap | Rs 698.8 crore |
Windlas Biotech Ltd. (WINDLAS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Windlas Biotech Ltd. (WINDLAS) has a P/E ratio of 31.29x, which is above the benchmark median of 31.16x, a difference of +0.42%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Windlas Biotech Ltd. (WINDLAS) has a ROE of 12.52%, which is above the benchmark median of 11.78%, a difference of +6.28%. Windlas Biotech Ltd. (WINDLAS) has a ROCE of 16.06%, which is above the benchmark median of 13.61%, a difference of +18%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Hester Biosciences Ltd. | HESTERBIO | 1,921.96 | 13.85 | 4.15 | 17.05 | 16.21 |
| Sakar Healthcare Ltd. | SAKAR | 1,920.95 | 59.53 | 6.42 | 6.48 | 8.43 |
| Venus Remedies Ltd. | VENUSREM | 2,221.86 | 18.43 | 3.12 | 16.79 | 21.88 |
| Indoco Remedies Ltd. | INDOCO | 2,246.67 | 397.58 | 2.24 | -10.13 | 0.79 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,296.22 | 138.89 | 2.94 | 4.88 | 6.1 |
Windlas Biotech Ltd. (WINDLAS) has a P/E ratio of 31.29x compared with the displayed peer median of 59.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.52% compares with a peer median of 6.48% across the companies shown in the table. ROCE stood at 16.06% versus the displayed peer median of 8.43%, providing a capital-efficiency comparison. Windlas Biotech Ltd. (WINDLAS) has a market capitalisation of Rs 2,050.73 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Windlas Biotech
- Windlas Biotech Share Price rose 7.19% to Rs 1,080 and touched a fresh 52-week high of Rs 1,093.05.
- The stock’s market capitalisation stood at Rs 2,050.73 crore during the session.
- P/E was 31.29, close to the same-industry median of 31.16.
- ROE of 12.52% and ROCE of 16.06% were both above the same-industry medians.
- Revenue for Jun 2026 was Rs 2,480.99 crore versus Rs 2,100.9 crore in Jun 2025.
About Windlas Biotech
Windlas Biotech Ltd. is classified under Healthcare and the Pharmaceuticals & Drugs industry. This company profile is the factual context used in Windlas Biotech Stock News and Windlas Biotech Share Price coverage. The company’s valuation and operating metrics are what shape the current discussion, along with its position in the supplied same-industry benchmark.
For readers following Windlas Biotech Share News, the business profile matters because it links the stock’s yearly high to a clearly defined industry and sector. Univest keeps the coverage focused on what is verified: company classification, market cap, financial ratios, and the day’s price event.
Track Windlas Biotech Share Price on Univest
Use Windlas Biotech Ltd. (WINDLAS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Windlas Biotech Share Price on Univest for live share price updates, market cap, shareholding pattern, fundamental ratios, 52-week levels and company news. Univest also helps readers follow Windlas Biotech Share Price Today alongside valuation context, peer comparison and sector data in one place. For investors scanning Windlas Biotech Latest News, that makes the page a practical reference point.
Windlas Biotech Share Price continues to be a stock to watch when market users search for Windlas Biotech Share Price Live, Windlas Biotech NSE, Windlas Biotech BSE and Windlas Biotech Stock Analysis. Univest presents the verified numbers in a structured format so readers can assess the event and the financial context together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Windlas Biotech Share Price hit a fresh 52-week high?
Ans. The supplied data confirms a fresh yearly high at Rs 1,093.05 and a 7.19% rise to Rs 1,080. It does not establish a company-specific catalyst, so the move should be read as verified price action.
What is Windlas Biotech Share Price today?
Ans. Windlas Biotech Share Price today is Rs 1,080. The stock closed higher than the previous close of Rs 1,007.6 and also touched Rs 1,093.05 during the session. The stock moved 7.19% during the session.
What is the 52-week high for Windlas Biotech?
Ans. The fresh 52-week high for Windlas Biotech was Rs 1,093.05. The current price of Rs 1,080 remains close to that session peak, which is why the stock is in focus today.
How much did Windlas Biotech Share Price rise today?
Ans. Windlas Biotech Share Price rose by Rs 72.4, or 7.19%, from the previous close of Rs 1,007.6. The day’s open was Rs 1,022.9 and the low was Rs 1,017.25. The stock moved 7.19% during the session.
What is the market cap of Windlas Biotech?
Ans. Windlas Biotech has a market capitalisation of Rs 2,050.73 crore. That places it above the same-industry median market cap of Rs 698.8 crore in the supplied benchmark. The company operates in the Healthcare sector.
Is Windlas Biotech expensive compared with peers?
Ans. Windlas Biotech’s P/E of 31.29 is close to the same-industry median of 31.16 and below the industry average of 48.22. Its P/B of 4.04 is above the median of 2.87 but near the average.
What do Windlas Biotech fundamentals show?
Ans. The company reports ROE of 12.52%, ROCE of 16.06%, EPS of 32.2 and book value of Rs 249.16. These figures provide a clear fundamental backdrop for Windlas Biotech Share Price.
How does Windlas Biotech compare with the healthcare industry benchmark?
Ans. Windlas Biotech’s P/E is close to the same-industry median, while ROE and ROCE are above the benchmark medians. That shows the stock is broadly aligned on valuation and slightly ahead on profitability metrics.
What does Windlas Biotech revenue data show?
Ans. Revenue rose from Rs 2,100.9 crore in Jun 2025 to Rs 2,480.99 crore in Jun 2026. Net profit moved from Rs 176.64 crore to Rs 176.53 crore in the same period.
Can investors track Windlas Biotech Share Price on Univest?
Ans. Yes. Univest tracks Windlas Biotech Share Price with live updates, market cap, valuation ratios, sector context and 52-week levels so readers can follow the stock in one place. The stock moved 7.19% during the session.
